Table S1 from PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

Doro Pereira, Luiza; Wielgos-Bonvallet, Monica; Misirlioglu, Selim; Khodadai-Jamayran, Alireza; Jelinic, Petar; Levine, Douglas A.

doi:10.1158/2767-9764.28443127

Table S1 from PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

https://doi.org/10.1158/2767-9764.28443127

journal contribution

posted on 2025-02-19, 08:40 authored by Luiza Doro Pereira, Monica Wielgos-Bonvallet, Selim Misirlioglu, Alireza Khodadai-Jamayran, Petar Jelinic, Douglas A. Levine

<p>Supplementary Table 1 shows enriched gene sets upregulated in CAOV3 cells treated with talazoparib.</p>

History

Related Materials

1.
DOI - Is supplement to PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

ARTICLE ABSTRACT

This work highlights how different PARPis, especially talazoparib, modulate immune-related gene expression in ovarian cancer cells, independent of the cGAS-STING pathway. These findings may improve our understanding of how different PARPis affect the immune system in various genetic backgrounds.

Usage metrics

Keywords

Dna Damage And Repair Gene amplification Oncogenes & Tumor Suppressors BRCA family Ovarian Cancer Small Molecule Agents

Licence

CC BY

Table S1 from PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

History

Related Materials

ARTICLE ABSTRACT

Usage metrics

Categories

Keywords

Licence

Exports